BC Environmental and Occupational Health Research Network

The Lymphoma Research Foundation’s Chronic Lymphocytic Leukemia Committee for Clinical Trials (CLLCCT) seeks proposals in CLL for translational or clinical studies using novel agents alone or in combination with existing therapies as part of Phase I and Phase II clinical trials being conducted by an institution or institutions with a successful clinical trial track record. Studies including one or more of the following examples are encouraged: pharmacokinetics, pharmacodynamics, pharmacogenomics, molecular diagnostics, etc. Priority of funding will be oriented toward those grants emphasizing inter- or multi-institutional collaboration.